Athersys Inc (ATHXQ)

[expediter13]

This week Dr. Harrington from Athersys Inc will present this...

Manufacturing and Clinical Development of MultiStem - A Drug-Like Cell Therapeutic
During the past decade, the number of cell therapies under evaluation in clinical studies has increased dramatically. In many instances, the manufacturing process used early in clinical development is not feasible for commercial production, due to high cost of goods, lack of scalability, supply chain constraints, and regulatory requirements. In this presentation, key scale up considerations aimed at producing a commercially successful product will be discussed.

John Harrington, Ph.D., Chief Scientific Officer, Athersys, Inc.

How can a Doctor working with a "to this point" know failed biologic present data on cost and scalability, supply chain, constraints, etc. The company has never sold or manufactured a biologic that has been saleable ?

In my opinion it is just another ploy to make it look like they are actually moving forward with a product. Huge waste of finances and a complete waste of time. If the product worked in just one phase II trial it MAY be worth the work to see if it is "all of the above" but if it doesnt work, yet.

It just makes no sense at all that Athersys keeps moving forward because they have nothing better to do with their time and money...

I am actually sick of it and going to do what is needed to contact the rest of the board... it is principal now, not money as much... Grant money waste on this stuff... is sickening...